PEDIATRICS Vol. 71 No. 5 May 1983, pp. 850-851
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by JOOS, T. H.
Right arrow Articles by PIERANTONI, W. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by JOOS, T. H.
Right arrow Articles by PIERANTONI, W. N.

Improved Method for Administration of Aerosol in Young Children

THAD H. JOOS MD1, PETER A. NICKLES MD1, and WAYNE N. PIERANTONI MD1

1 20136 Mack Ave, Grosse Pointe Woods, Michigan

The child less than 3 years of age with bronchospastic lung disease often poses a challenge to the effective administration of beta2-agonists as proposed in a review article by Tabachnik and Levison.1 A mask that fits properly over the nose and mouth is viewed by the patient as an unwanted therapeutic intervention.

Since Jan 1, 1982, we have employed an Ohio Face Tent type enclosure for the administration of aerosolized isoetharine to a group of 20 such children (Fig 1). Nebulization in the home or office was provided by a portable electrically powered unit, whereas in the hospital either central compressed air or oxygen was used.